275 related articles for article (PubMed ID: 31685414)
1. Autoimmune-mediated congenital heart block.
Wainwright B; Bhan R; Trad C; Cohen R; Saxena A; Buyon J; Izmirly P
Best Pract Res Clin Obstet Gynaecol; 2020 Apr; 64():41-51. PubMed ID: 31685414
[TBL] [Abstract][Full Text] [Related]
2. Neonatal lupus: bedside to bench and back.
Buyon JP
Scand J Rheumatol; 1996; 25(5):271-6. PubMed ID: 8921918
[TBL] [Abstract][Full Text] [Related]
3. The clinical spectrum of autoimmune congenital heart block.
Brito-Zerón P; Izmirly PM; Ramos-Casals M; Buyon JP; Khamashta MA
Nat Rev Rheumatol; 2015 May; 11(5):301-12. PubMed ID: 25800217
[TBL] [Abstract][Full Text] [Related]
4. [Congenital heart block associated with maternal anti SSA/SSB antibodies :a report of four cases].
Ayed K; Gorgi Y; Sfar I; Khrouf M
Pathol Biol (Paris); 2004 Apr; 52(3):138-47. PubMed ID: 15063933
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune congenital heart block: complex and unusual situations.
Brito-Zerón P; Izmirly PM; Ramos-Casals M; Buyon JP; Khamashta MA
Lupus; 2016 Feb; 25(2):116-28. PubMed ID: 26762645
[TBL] [Abstract][Full Text] [Related]
6. Congenital heart block in neonatal lupus: the pediatric cardiologist's perspective.
Friedman DM; Rupel A; Glickstein J; Buyon JP
Indian J Pediatr; 2002 Jun; 69(6):517-22. PubMed ID: 12139139
[TBL] [Abstract][Full Text] [Related]
7. Interferons and innate immune activation in autoimmune congenital heart block.
Ambrosi A; Thorlacius GE; Sonesson SE; Wahren-Herlenius M
Scand J Immunol; 2021 Jan; 93(1):e12995. PubMed ID: 33188653
[TBL] [Abstract][Full Text] [Related]
8. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of congenital heart block.
Ambrosi A; Sonesson SE; Wahren-Herlenius M
Exp Cell Res; 2014 Jul; 325(1):2-9. PubMed ID: 24434353
[TBL] [Abstract][Full Text] [Related]
10. Recurrent congenital heart block in neonatal lupus.
Escobar MC; Gómez-Puerta JA; Albert D; Ferrer Q; Girona J
Clin Rheumatol; 2007 Jul; 26(7):1161-3. PubMed ID: 16586043
[TBL] [Abstract][Full Text] [Related]
11. Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes.
Miranda ME; Tseng CE; Rashbaum W; Ochs RL; Casiano CA; Di Donato F; Chan EK; Buyon JP
J Immunol; 1998 Nov; 161(9):5061-9. PubMed ID: 9794444
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune-associated congenital heart block: dissecting the cascade from immunologic insult to relentless fibrosis.
Clancy RM; Buyon JP
Anat Rec A Discov Mol Cell Evol Biol; 2004 Oct; 280(2):1027-35. PubMed ID: 15368347
[TBL] [Abstract][Full Text] [Related]
13. Identification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigen.
Claus R; Hickstein H; Külz T; Lenschow U; Meiske D; Kotitschke A; Thiesen HJ; Lorenz P
Rheumatol Int; 2006 Aug; 26(10):886-95. PubMed ID: 16402218
[TBL] [Abstract][Full Text] [Related]
14. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis.
Nield LE; Silverman ED; Taylor GP; Smallhorn JF; Mullen JB; Silverman NH; Finley JP; Law YM; Human DG; Seaward PG; Hamilton RM; Hornberger LK
Circulation; 2002 Feb; 105(7):843-8. PubMed ID: 11854125
[TBL] [Abstract][Full Text] [Related]
15. Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies.
Askanase AD; Friedman DM; Copel J; Dische MR; Dubin A; Starc TJ; Katholi MC; Buyon JP
Lupus; 2002; 11(3):145-51. PubMed ID: 11999879
[TBL] [Abstract][Full Text] [Related]
16. Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies.
Cimaz R; Spence DL; Hornberger L; Silverman ED
J Pediatr; 2003 Jun; 142(6):678-83. PubMed ID: 12838197
[TBL] [Abstract][Full Text] [Related]
17. Congenital heart block maternal sera autoantibodies target an extracellular epitope on the α1G T-type calcium channel in human fetal hearts.
Strandberg LS; Cui X; Rath A; Liu J; Silverman ED; Liu X; Siragam V; Ackerley C; Su BB; Yan JY; Capecchi M; Biavati L; Accorroni A; Yuen W; Quattrone F; Lung K; Jaeggi ET; Backx PH; Deber CM; Hamilton RM
PLoS One; 2013; 8(9):e72668. PubMed ID: 24039792
[TBL] [Abstract][Full Text] [Related]
18. Neonatal lupus syndromes.
Buyon JP; Clancy RM
Curr Opin Rheumatol; 2003 Sep; 15(5):535-41. PubMed ID: 12960477
[TBL] [Abstract][Full Text] [Related]
19. Benefits of fetal echocardiographic surveillance in pregnancies at risk of congenital heart block: single-center study of 212 anti-Ro52-positive pregnancies.
Sonesson SE; Ambrosi A; Wahren-Herlenius M
Ultrasound Obstet Gynecol; 2019 Jul; 54(1):87-95. PubMed ID: 30620419
[TBL] [Abstract][Full Text] [Related]
20. Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases.
Fredi M; Argolini LM; Angeli F; Trespidi L; Ramoni V; Zatti S; Vojinovic T; Donzelli D; Gazzola FG; Xoxi B; Andreoli L; Lojacono A; Ferrazzi E; Montecucco C; Chighizola CB; Meroni PL; Franceschini F; Cimaz R; Caporali R; Tincani A; Gerosa M
Clin Exp Rheumatol; 2023 Mar; 41(3):685-693. PubMed ID: 36377571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
